Leader Allergy Relief label

Leader Allergy Relief

Leader Allergy Relief Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

liver or kidney disease. Your doctor should determine if you need a different dose.

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Leader Allergy Relief Manufacturers

  • Leader Allergy Relief | Cardinal Health
    No Recall

    Leader Allergy Relief | Cardinal Health

    Leader Allergy Relief | Cardinal Health
    place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
  • Leader Allergy Relief | Cardinal Health
    No Recall

    Leader Allergy Relief | Cardinal Health

    Leader Allergy Relief | Cardinal Health
    place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
  • Leader Allergy Relief | Remedyrepack Inc.
    No Recall

    Leader Allergy Relief | Remedyrepack Inc.

    Leader Allergy Relief | Remedyrepack Inc.

    Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD (2.1 ) Adults 40 mg Once Daily for up to 8 wks   Children (5 years and older) 
    ≥ 15 kg to < 40 kg
     ≥ 40 kg
    20 mg
    40 mg  
    Once Daily for up to 8 wks Maintenance of Healing of Erosive Esophagitis (2.1 ) Adults 40 mg Once Daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (2.1 ) Adults 40 mg Twice Daily

    See full prescribing information for adminisration instructions

     

     Pantoprazole is supplied as delayed-release tablets. The recommended dosages are outlined in Table 1.

     Table 1: Recommended Dosing Schedule for Pantoprazole

    Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD Adults 40 mg Once daily for up to 8 weeks* Children (5 years and older)
     ≥ 15 kg to < 40 kg
     ≥ 40 kg
    20 mg
    40 mg
    Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis Adults 40 mg Once daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome Adults 40 mg Twice daily**

     * For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered.
     ** Dosage regimens should be adjusted to individual patient needs and should continue for as long as clinically indicated. Doses up to 240 mg daily have been administered.

     

     Directions for method of administration for pantoprazole sodium delayed-release tablets are presented in Table 2.

    Table 2: Administration Instructions

    Formulation

    Route

    Instructions*

    Delayed-Release Tablets

    Oral

    Swallowed whole, with or without food

     * Patients should be cautioned that Pantoprazole Sodium Delayed-Release Tablets should not be  split, chewed, or crushed.

    Pantoprazole Sodium Delayed-Release Tablets USP

    Pantoprazole sodium delayed-release tablets USP should be swallowed whole, with or without food in the stomach. If patients are unable to swallow a 40 mg tablet, two 20 mg tablets may be taken. Concomitant administration of antacids does not affect the absorption of pantoprazole sodium delayed‑release tablets USP.